Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inclusion Body Myositis, Sporadic”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT02753530
What this trial is testing

Study of Arimoclomol in Inclusion Body Myositis (IBM)

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 152
Testing effectiveness (Phase 2)Study completedNCT00079768
What this trial is testing

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

Who this might be right for
Myositis, Inclusion Body
National Institute of Neurological Disorders and Stroke (NINDS) 20
Large-scale testing (Phase 3)Study completedNCT02250443
What this trial is testing

Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Very early researchLooking for participantsNCT06479863
What this trial is testing

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)Idiopathic Inflammatory Myopathies
Austin Neuromuscular Center 10
Large-scale testing (Phase 3)Study completedNCT00769860
What this trial is testing

Arimoclomol in Sporadic Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Richard Barohn, MD 24
Not applicableStudy completedNCT01902940
What this trial is testing

Natural History in CCFDN and IBM Syndromes

Who this might be right for
Inclusion Body Myositis, SporadicInclusion Body Myopathy, Autosomal-recessiveInclusion Body Myopathy, Autosomal-dominant+1 more
Ludwig-Maximilians - University of Munich 350
Large-scale testing (Phase 3)Ended earlyNCT04049097
What this trial is testing

Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 121
Not applicableStudy completedNCT02317094
What this trial is testing

Blood-flow Restricted Exercise in Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
University of Southern Denmark 22
Early research (Phase 1)Study completedNCT03440034
What this trial is testing

Study of Pioglitazone in Sporadic Inclusion Body Myositis

Who this might be right for
MyositisInclusion Body MyositisMuscular Diseases+3 more
Johns Hopkins University 19
Testing effectiveness (Phase 2)WithdrawnNCT03710941
What this trial is testing

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
Regeneron Pharmaceuticals
Early research (Phase 1)Study completedNCT01519349
What this trial is testing

Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis

Who this might be right for
Becker Muscular DystrophySporadic Inclusion Body Myositis
Nationwide Children's Hospital 15
Not applicableUnknownNCT02735447
What this trial is testing

Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study

Who this might be right for
Sporadic Inclusion Body Myositis
La-ser Europe Limited 190
Not applicableStudy completedNCT00030212
What this trial is testing

Immune Abnormalities in Sporadic Inclusion Body Myositis

Who this might be right for
SporadicInclusion BodyMyositis
National Institute of Neurological Disorders and Stroke (NINDS) 80
Early research (Phase 1)Study completedNCT04421677
What this trial is testing

Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis

Who this might be right for
Inclusion Body MyositisSporadic Inclusion Body Myositis
University of Kansas Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06536166
What this trial is testing

Ruxolitinib Treatment in Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris 80
Large-scale testing (Phase 3)Study completedNCT01925209
What this trial is testing

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 251
Large-scale testing (Phase 3)Study completedNCT02573467
What this trial is testing

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 211
Testing effectiveness (Phase 2)Study completedNCT01423110
What this trial is testing

Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 14
Not applicableActive Not RecruitingNCT05046821
What this trial is testing

Sporadic Inclusion Body Myositis Natural History Study

Who this might be right for
Sporadic Inclusion Body MyositisInclusion Body Myositis
University of California, Irvine 150